// Google Adsense

Thursday, April 2, 2020

COVID-19 vaccine candidate shows promise

(c) futurism.com
University of Pittsburgh School of Medicine scientists have announced a potential vaccine against SARS-CoV-2, the new coronavirus causing the COVID-19 pandemic. When tested in mice, the vaccine, delivered through a fingertip-sized patch, produces antibodies specific to SARS-CoV-2 at quantities thought to be sufficient for neutralizing the virus.

Friday, November 30, 2018

Is being a night owl bad for your health?

from Amazon.com
Night owls may have a higher risk of suffering from heart disease and type 2 diabetes than early risers.

In the first ever international review of studies analyzing whether being an early riser or a night owl can influence your health, researchers have uncovered a growing body of evidence indicating an increased risk of ill health in people with an evening preference as they have more erratic eating patterns and consume more unhealthy foods.

Friday, September 28, 2018

Color-Changing Sensor Detects Signs of Eye Damage in Tears

(c) UIUC
A new point-of-care rapid-sensing device can detect a key marker of eye injury in minutes – a time frame crucial to treating eye trauma.

Researchers develop sugar-powered sensor to detect and prevent disease

(c) WSU
Researchers at Washington State University have developed an implantable, biofuel-powered sensor that runs on sugar and can monitor a body’s biological signals to detect, prevent and diagnose diseases.

Wednesday, May 30, 2018

FDA approves HumanOptics AG's CustomFlex Artificial iris

(c) OphthalmologyWeb
The U.S. Food and Drug Administration today approved the first stand-alone prosthetic iris in the United States, a surgically implanted device to treat adults and children whose iris (the colored part of the eye around the pupil) is completely missing or damaged due to a congenital condition called aniridia or other damage to the eye.

Wednesday, March 7, 2018

FDA grants authorization to 23andMe for direct-to-consumer genetic test for cancer risk

(c) 23andMe
23andMe, Inc. has received the first-ever FDA authorization for a direct-to-consumer genetic test for cancer risk. The authorization allows the company to provide customers, without a prescription, information on three genetic variants found on the BRCA1 and BRCA2 genes known to be associated with higher risk for breast, ovarian and prostate cancer.

Friday, March 2, 2018

Diabetes may be a group of five different diseases

(c) CDC
A new analysis published in The Lancet Diabetes and Endocrinology indicates researchers were able to distinguish 5 new subgroups of patients with adult-onset diabetes, representing a first step toward precision medicine for the roughly 415 million patients with the chronic condition.